The report is part of FDA's Critical Path Initiative, established in 2004 to discern what challenges exist in moving a promising drug, biologic or device along the critical path from discovery, ...

The FDA’s recommendation. In March 2006, the FDA released the Critical Path Opportunities List of 76 projects that they believe, if pursued, will increase efficiency, predictability and ...

New Critical Path Report Highlights Research Needed to Foster Generic Drug Development The U.S. Food and Drug Administration (FDA) today issued the "Critical Path Opportunities for Generic Drugs ...